drugset / Trial / NCT07116811

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

NCT07116811

Phase 3 Not yet recruiting 364 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of steroids treatment compared with placebo in preserving facial nerve function after craniotomy in patients with vestibular schwannoma who have not received preoperative treatment and have good intraoperative facial nerve function.

Timeline

Start
2025-09-01
Primary completion
2026-09-30
Completion
2027-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 80 mg Intravenous
Subject Prednisone Other / unclassified 20 mg Oral